Total parenteral nutrition needs in different types of short bowel syndrome

M.C. Gouttebel, B. Saint‐Aubert, C. Astre, +1

Digestive Diseases and Sciences

NutritionBody CompositionNutritional RequirementShort Bowel SyndromeClinical Nutrition +8

Intestinal adaptation in patients with short bowel syndrome

M.C. Gouttebel, B Aubert, C Colette, +3

Digestive Diseases and Sciences

NutritionFunctional Gastrointestinal DisorderShort Bowel SyndromeGastroenterologyClinical Gastroenterology +1

Validation of a food-frequency questionnaire using multiple-day records and biochemical markers: application of the triads method.

J.-P. Daurès, Marianne Gerber, Jacqueline Scali, +3

PubMed

Colorectal carcinoma in patients younger than 40 years of age.Montpellier cancer institute experience with 78 patients

J Domergue, MOUSA ISMAIL, C. Astre, +4

Cancer

Bayesian estimate of vinorelbine pharmacokinetic parameters in elderly patients with advanced metastatic cancer.

Anne‐Cécile Gauvin, Frédéric Pinguet, Stéphane Culine, +3

PubMed

Elderly PatientsPharmacotherapyPhysiologically-based Pharmacokinetic ModelingIndividual Pharmacokinetic ParametersBioanalysis +14

Pharmacokinetics of high-dose intravenous melphalan in patients undergoing peripheral blood hematopoietic progenitor-cell transplantation.

Frédéric Pinguet, Pascal Martel, Michel Fabbro, +5

PubMed

Blood CellPharmacotherapyHigh-dose Intravenous MelphalanHematological MalignancyLaboratory Hematology +16

Determination of 5-fluorouracil and its main metabolites in plasma by high-performance liquid chromatography: Application to a pharmacokinetic study

Jean Michel Joulia, Frédéric Pinguet, Pierre Yves Grosse, +2

Journal of Chromatography B Biomedical Sciences and Applications

Pharmaceutical ScienceMain MetabolitesGas ChromatographyMedicinePharmacokinetic Study +9

Plasma and salivary pharmacokinetics of 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer receiving 5-FU bolus plus continuous infusion with high-dose folinic acid

Jean Michel Joulia, Frédéric Pinguet, Marc Ychou, +3

European Journal of Cancer

Gastrointestinal OncologyMedicineMetronomic TherapyPharmacologyColorectal Cancer +6

A phase I and pharmacokinetic study of melphalan using a 24-hour continuous infusion in patients with advanced malignancies.

Frédéric Pinguet, Stéphane Culine, Françoise Bressolle, +4

PubMed

OncologyMelphalan MtdMedicinePharmacokinetic StudyPharmacotherapy +11

Population pharmacokinetics of melphalan, infused over a 24-hour period, in patients with advanced malignancies

Philippe Mougenot, Fr�d�ric Pinguet, Michel Fabbro, +4

Cancer Chemotherapy and Pharmacology

OncologyPharmacology24-Hour PeriodPharmacotherapyAnti-cancer Agent +7